Sociodemographic and clinical predictors of compliance with antidepressants for depressive disorders: Systematic review of observational studies

Patient Preference and Adherence

Volumn 7, Issue , 2013, Pages 151-169

  Rivero Santana, Amado ^a   Perestelo Perez, Lilisbeth ^b,c   Pérez Ramos, Jeanette ^a   Serrano Aguilar, Pedro ^b,c   De las Cuevas, Carlos ^b,d  

^a Canary Islands Foundation for Health and Research (FUNCIS)   (Spain)

^b Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC)   (Spain)

^c Canary Islands Health Service   (Spain)

^d UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Adherence; Antidepressants; Compliance; Depression; Predictors

Indexed keywords

ANTIDEPRESSANT AGENT;

CAUCASIAN; COMORBIDITY; DEMOGRAPHY; DEPRESSION; DISEASE SEVERITY; ETHNIC GROUP; HEALTH STATUS; HUMAN; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; QUALITY OF LIFE; REVIEW; SOCIAL ASPECT; SUBSTANCE ABUSE; SYSTEMATIC REVIEW;

EID: 84875046136     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S39382     Document Type: Review

References (61)

1. Sobocki P, Jonsson B, Angst J, Rehnberg C. Cost of depression in Europe. J Ment Health Policy Econ. 2006;9:87-98.
2. Murray CJL, López AD. The Global Burden of Disease, a Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Harvard, MA: Harvard University Press; 1996.
3. National Collaborating Centre for Mental Health. Depression: The Treatment and Management of Depression in adults (Updated Edition). National Clinical Practice Guideline Number 90. London, UK: British Psychological Society and Royal College of Psychiatrists; 2009.
4. Solomon DA, Keller MB, Leon AC, et al. Multiple recurrences of major depressive disorder. Am J Psychiatry. 2000;157:229-233.
5. Karasu TB, Gelenberg A, Merriam A, et al. Practice Guideline for the Treatment of Patients with Major Depressive Disorder, 2nd ed. Washington, DC: American Psychiatric Association; 2000.
6. Haynes RB. Introduction. In: Haynes RB, Taylor WD, Sacket DL, editors. Compliance in Health Care. Baltimore, MD: Johns Hopkins University Press; 1979.
7. Horne R, Weinman J, Barber N, Elliott R, Morgan M, Cribb A. Concordance, adherence and compliance in medicine taking. Report for the National Coordinating Centre for NHS Service Delivery and Organisation R and D (NCCSDO). London, UK: National Coordinating Centre for NHS Service Delivery and Organisation Research and Development; 2005. Available from: http://www.medslearning.leeds.ac.uk/pages/documents/useful_docs/76-final-report%5B1%5D.pdf. Accessed February 5, 2013.
8. Demyttenaere K. Risk factors and predictors of compliance in depression. Eur Neuropsychopharmacol. 2003;13:S69-S75.
9. Vos T, Haby MM, Barendregt JJ, Kruijshaar M, Corry J, Andrews G. The burden of major depression avoidable by longer-term treatment strategies. Arch Gen Psychiatry. 2004;61:1097-1103.
10. Bulloch AG, Patten SB. Non-adherence with psychotropic medications in the general population. Soc Psychiatry Psychiatric Epidemiol. 2010;45:47-56.
11. Demyttenaere K. Compliance during treatment with antidepressants. J Affect Disord. 1997;43:27-39.
12. Feetam C. Medicine taking behaviour in depression-Part 2. Prog Neurol Psychiatry. 2009;13:30-33.
13. Demyttenaere K, Enzlin P, Dewé W, et al. Compliance with antidepressants in a primary care setting, 1: beyond lack of efficacy and adverse events. J Clin Psychiatry. 2001;62:30-33.
14. Kwon A, Bungay KM, Pei Y, et al. Antidepressant use: concordance between self-report and claims records. Med Care. 2003;41:368-374.
15. Myers ED, Branthwaite A. Out-patient compliance with antidepressant medication. Br J Psychiatry. 1992;160:83-86.
16. Shi L, Liu J, Fonseca V, Walker P, Kalsekar A, Pawaskar M. Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health Qual Life Outcomes. 2010;8:99.
17. Demyttenaere K, Enzlin P, Dewé W, et al. Compliance with antidepressants in a primary care setting, 2: the influence of gender and type of impairment. J Clin Psychiatry. 2001;62:34-37.
18. Demyttenaere K. Compliance and acceptance in antidepressant treatment. Int J Psychiatry Clin Pract. 2001;5:29-35.
19. Sher I, McGinn L, Sirey JA, Meyers V. Effects of caregivers' perceived stigma and causal beliefs on patients' adherence to antidepressant treatment. Psychiatr Serv. 2005;56:564-569.
20. Sirey JA, Bruce ML, Alexopoulos GS, Perlick DA, Friedman SJ, Meyers BS. Perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatr Serv. 2001;52: 1615-1620.
21. Aikens JE, Nease DE, Nau DP, Klinkman MS, Schwenk TL. Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication. Ann Fam Med. 2005;3:23-30.
22. Akincigil A, Bowblis JR, Levin C, Walkup JT, Saira J, Crystal S. Adherence to antidepressant treatment among privately insured patients diagnosed with depression. Med Care. 2007;45:363-369.
23. Ayalon L, Areán PA, Alvidrez J. Adherence to antidepressant medications in black and Latino elderly patients. Am J Geriatr Psychiatry. 2005;13:572-580.
24. Bull SA, Hu XH, Hunkeler EM, et al. Discontinuation of use and switching of antidepressants influence of patient-physician communication. JAMA. 2002;288:1403-1409.
25. Chen SY, Hansen RA, Gaynes BN, Farley JF, Morrissey JP, Maciejewski ML. Guideline-concordant antidepressant use among patients with major depressive disorder. Gen Hosp Psychiatry. 2010;32:360-367.
26. Crown WH, Treglia M, Meneades L, White A. Long-term costs of treatment for depression: impact of drug selection and guideline adherence. Value Health. 2001;4:295-307.
27. Donohue JM, Berndt ER, Rosenthal M, Epstein AM, Frank RG. Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression. Med Care. 2004;42:1176-1185.
28. Granger AL, Fehnel SE, Hogue SL, Bennett L, Edin HM. An assessment of patient preference and adherence to treatment with Wellbutrin SR: a web-based survey. J Affect Disord. 2006;90:217-221.
29. Keeley R, Smith M, Miller J. Somatoform symptoms and treatment nonadherence in depressed family medicine outpatients. Arch Fam Med. 2000;9:46-54.
30. Keeley RD, Davidson AJ, Crane LA, Matthews B, Pace W. An association between negatively biased response to neutral stimuli and antidepressant nonadherence. J Psychosom Res. 2007;62:535-544.
31. Lin HC, Erickson SR, Balkrishnan R. Antidepressant utilization, adherence, and health care spending in the United States: the case of MDD patients 2000-2007. Health Outcomes Res Med. 2011;2:e79-e89.
32. Madsen JW, McQuaid JR, Craighead WE. Working with reactant patients: are we prescribing nonadherence? Depress Anxiety. 2009;26:129-134.
33. McLaughlin T, Hogue SL, Stang PE. Once-daily bupropion associated with improved patient adherence compared with twice-daily bupropion in treatment of depression. Am J Ther. 2007;14:221-225.
34. Merrick EL, Hodgkin D, Panas L, Soumerai SB, Ritter G. Is customization in antidepressant prescribing associated with acute-phase treatment adherence? J Pharm Health Serv Res. 2012;3:11-16.
35. Pfeiffer PN, Ganoczy D, Zivin K, Valenstein M. Benzodiazepines and adequacy of initial antidepressant treatment for depression. J Clin Psychopharmacol. 2011;31:360-364.
36. Olfson M, Marcus SC, Tedeschi M, Wan GJ. Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry. 2006;163:101-108.
37. Sanglier T, Saragoussi D, Milea D, Auray JP, Valuck RJ, Tournier M. Comparing antidepressant treatment patterns in older and younger adults: a claims database analysis. J Am Geriatr Soc. 2011;59: 1197-1205.
38. Stang P, Suppapanaya N, Hogue SL, Park D, Rigney U. Persistence with once-daily versus twice-daily bupropion for the treatment of depression in a large managed-care population. Am J Ther. 2007;14:241-246.
39. Voils CI, Steffens DC, Flint EP, Bosworth HB. Social support and locus of control as predictors of adherence to antidepressant medication in an elderly population. Am J Geriatr Psychiatry. 2005;13:157-165.
40. White TJ, Vanderplas A, Ory C, Dezii CM, Chang E. Economic impact of patient adherence with antidepressant therapy within a managed care organization. Dis Manag Health Outcome. 2003;11:817-822.
41. Woolley SB, Fredman L, Goethe JW, Lincoln AK, Heeren T. Hospital patients' perceptions during treatment and early discontinuation of serotonin selective reuptake inhibitor antidepressants. J Clin Psychopharmacol. 2010;30:716-719.
42. Wu CH, Erickson SR, Piette JD, Balkrishnan R. The association of race, comorbid anxiety, and antidepressant adherence among Medicaid enrollees with major depressive disorder. Res Social Adm Pharm. 2012;8:193-205.
43. Burra TA, Chen E, Mclntyre RS, Grace SL, Blackmore ER, Stewart DE. Predictors of self-reported antidepressant adherence. Behav Med. 2007;32:127-134.
44. Cohen NL, Ross EC, Bagby RM, Farvolden P, Kennedy SH. The 5-factor model of personality and antidepressant medication compliance. Can J Psychiatry. 2004;49:106-113.
45. Roca M, Armengol S, Monzón S, Salva J, Gili M. Adherence to medication in depressive patients. J Clin Psychopharmacol. 2011;31: 541-543.
46. Oller-Canet S, Lacasta-Tintorer D, Castro Rodríguez JI, et al. Do depressed patients comply with treatments prescribed? A crosssectional study of adherence to the antidepressant treatment. Actas Esp Psiquiatr. 2011;39:288-293.
47. Hung CI, Wang S, Liua CY, Hsua SC, Yange CH. Comorbidities and factors related to discontinuation of pharmacotherapy among outpatients with major depressive disorder. Compr Psychiatry. 2011;52:370-377.
48. Yeh MY, Sung SC, Yorker BC, Sun CC, Kuo YL. Predictors of adherence to an antidepressant medication regimen among patients diagnosed with depression in Taiwan. Issues Ment Health Nurs. 2008;29:701-717.
49. Maidment R, Livingston G, Katona C. 'Just keep taking the tablets': adherence to antidepressant treatment in older people in primary care. Int J Geriatr Psychiatry. 2002;17:752-757.
50. Russell J, Kazantzis N. Medication beliefs and adherence to antidepressants in primary care. N Z Med J. 2008;121:14-20.
51. Zivin K, Kales HC. Adherence to depression treatment in older adults: a narrative review. Drugs Aging. 2008;25:559-571.
52. Bosworth HB, Voils CI, Potter GC, Steffens DC. The effects of antidepressant medication adherence as well as psychosocial and clinical factors on depression outcome among older adults. Int J Geriatr Psychiatry. 2008;23:129-134.
53. Ibrahim S, Zhang A, Mercer M, Baughman M, Kwoh C. Inner city African-American elderly patients' perceptions and preferences for the care of chronic knee and hip pain: findings from focus groups. J Gerontol. 2004;59:1318-1322.
54. Jimenez DE, Bartels SJ, Cardenas V, Dhaliwal SS, Alegría M. Cultural beliefs and mental health treatment preferences of ethnically diverse older adult consumers in primary care. Am J Geriatr Psychiatry. 2012;20:533-542.
55. Cooper LA, Gonzales JJ, Gallo JJ, et al. The acceptability of treatment for depression among African-American, Hispanic, and white primary care patients. Med Care. 2003;41:479-489.
56. Givens JL, Houston TK, Van Voorhees BW, Ford DE, Cooper LA. Ethnicity and preferences for depression treatment. Gen Hosp Psychiatry. 2007;29:182-191.
57. Aranda JM, Vazquez R. Awareness of hypertension and diabetes in the Hispanic community. Clin Cornerstone. 2004;6:7-13.
58. Townsend MS. Patient-driven education materials: low-literate adults increase understanding of health messages and improve compliance. Nurs Clin North Am. 2011;46:367-378.
59. Demyttenaere K. Noncompliance with antidepressants: who's to blame? Int Clin Psychopharmacol. 1998;13:19-25.
60. Demyttenaere K, Adelin A, Patrick M, Walthere D, Katrien DB, Sangeleer M. Six-month compliance with antidepressant medication in the treatment of major depressive disorder. Int Clin Psychopharmacol. 2008;23:36-42.
61. Brook OH, van Hout HPJ, Stalman WAB, de Haan M. Nontricyclic antidepressants: predictors of nonadherence. J Clin Psychopharmacol. 2006;26:643-647.